Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations.
about
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesNonsense Suppression as an Approach to Treat Lysosomal Storage Diseases.Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates.Structure-Activity Relationship Study of Leucyl-3-epi-deoxynegamycin for Potent Premature Termination Codon Readthrough.Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
P2860
Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Design of Novel Aminoglycoside ...... es-Causing Nonsense Mutations.
@en
type
label
Design of Novel Aminoglycoside ...... es-Causing Nonsense Mutations.
@en
prefLabel
Design of Novel Aminoglycoside ...... es-Causing Nonsense Mutations.
@en
P2093
P2860
P1476
Design of Novel Aminoglycoside ...... es-Causing Nonsense Mutations.
@en
P2093
Boris Smolkin
Michal Shavit
Narayana Murthy Sabbavarapu
Timor Baasov
Valery Belakhov
Yarden Degani
P2860
P304
P356
10.1021/ACSMEDCHEMLETT.6B00006
P577
2016-02-08T00:00:00Z